Terminated PHASE2 INTERVENTIONAL 1-arm NCT00642083

Stenting of Haemodialysis Acces Trial (SHARE)

Stenting of Haemodialysis Acces Re-stenosis Trial (SHARE Trial)

Sponsor: Rijnstate Hospital

Updated 5 times since 2017 Last updated: Dec 14, 2011 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow inclusion

Other terminated trials from Rijnstate Hospital

See all terminations from Rijnstate Hospital

Listed as NCT00642083, this PHASE2 trial focuses on Outflow Stenosis and remains terminated or withdrawn. Sponsored by Rijnstate Hospital, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rijnstate Hospital
W.L.Gore & Associates

Data source: Rijnstate Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arnhem, Netherlands